Switzer TV

In this week’s Switzer Investing TV, Paul Rickard sits down with chartist and market analyst Mike Gable to break down the big ideas driving today’s bull market — from rare earths and uranium to the comeback stories in healthcare and banking.

They look at what’s powering the ASX200’s latest rally, whether the US market still has room to run, and which sectors could surprise next. Plus, Gable shares how he’s positioning in gold, why CSL might finally be turning the corner, and where he sees upside in Macquarie.

In this episode:

• The ASX200’s breakout — sustainable or overdone?

• Rare earths vs lithium: is history repeating?

• Uranium and gold: the commodities back in focus

• Has CSL bottomed, and what’s next for healthcare?

• The banks and Macquarie — are they about to run again?

If you’re looking for market insight that blends technical charts with fundamental reasoning, this is a must-watch for every Australian investor.

Hosted by Paul Rickard | Guest: Mike Gable, Managing Director, Fairmont Equities.

Switzer Investing TV | 20 Oct 2025: Are rare earths about to get the Lithium hosing? Plus: Can US shares run even higher, and will the ASX200 follow?

We break down the big ideas driving today’s bull market: from rare earths and uranium to the comeback stories in healthcare and banking.

More videos

My knee replacement

Dr Ross Walker shares his own experience of having a total knee replacement.

Series: ,
Mad about Money Live

Tune in to find out the latest money and market news with Peter Switzer and Paul Rickard.

Series: ,
We pinpoint some tech stocks you don't want to ignore!

Peter Switzer is joined by Burman Invest's Julia Lee, Medallion's Michael Wayne, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
The link between COVID-19 and heart disease

Dr Ross Walker looks at whether there is any connection between the Coronavirus and drugs used to treat cardiovascular disease.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
Is Mesoblast the biomedical stock you have to have? + Freelancer: stock on the way up?

Peter Switzer is joined by Burman Invest's Julia Lee, Freelancer.com's Matt Barrie, Vanguard's Robin Bowerman and Switzer's Paul Rickard.

Series: ,
What is a viral load?

Dr Ross Walker looks at viral load in relation to COVID-19 and which people are most at risk.

Series: ,
Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series: ,
Tech stocks on the slide! Which stocks are the best buys?

On this week's show, Peter Switzer is joined by Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
How to boost your immunity

Dr Ross Walker explains how you can boost your immunity and which vitamins will give you an extra boost.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
7 Experts! Their One Best Stock! Plus, CEO of NextDC - Check Out The Future!

Peter Switzer talks to the experts about the best companies coming out of reporting season, plus NextDC CEO Craig Scroggie.

Series: ,
1 40 41 42 43 44 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram